UFC women's strawweight contender Iasmin Lucindo has accepted a nine-month suspension for violating the promotion's anti-doping policy, it was announced Wednesday by UFC anti-doping partner Combat Sports Anti-Doping (CSAD).
Lucindo, 24, tested positive for mesterolone, an anabolic steroid that is primarily used to treat low testosterone and male infertility, from an out-of-competition sample collected Sept. 24, 2025 in Brazil. As a result, Lucindo (18-6 MMA, 5-2 UFC) was pulled from her scheduled Dec. 13 fight against Gillian Robertson at UFC on ESPN 73.
Lucindo's nine-month suspension is retroactive to Sept. 24, 2025 and will conclude June 24.
According to CSAD, Lucindo cooperated with its investigation, which found that she did not intentionally use mesterolone to gain a performance advantage and that her low-level adverse finding resulted from a contaminated supplement. Lucindo provided documentation from a Brazilian pharmacy she frequented that indicated it regularly compounded products containing mesterolone, including in potential legal dietary supplements that Lucindo used.
Lucindo last competed Aug. 9, 2025, winning a unanimous decision against veteran Angela Hill. It was the fifth win in her past six UFC appearances, with her only loss to Amanda Lemos.
This article originally appeared on MMA Junkie: UFC women's contended accepts nine-month anti-doping suspension
